© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Praxis Precision Medicines, Inc. (PRAX) shows an Average True Range (ATR) of 17.73 and an Enterprise Value of 795.07M. Its average trading volume over the past 3 months is 1.02M, indicating liquidity. These fundamental metrics provide insight into PRAX's underlying financial health and market activity.
Praxis Precision Medicines, Inc. (PRAX) technical indicators as of December 22, 2025: the SMA 20 is 18.57%, SMA 50 at 42.93%, and SMA 200 at 240.53%. The RSI 14 value is 69.53, suggesting its current momentum. These technical analysis signals help assess PRAX's price trends and potential future movements.
Praxis Precision Medicines, Inc. (PRAX) stock performance overview as of December 22, 2025: The 52-week high is $282.99 (currently -3.56% below), and the 52-week low is $26.7 (currently 922.17% above). Over the past year, PRAX's performance is 288.89%, compared to the S&P 500's 12.87% change.
According to market data, Praxis Precision Medicines, Inc. (PRAX) stock's recent performance metrics show that over the last month, PRAX is 48.22%, with a Year-to-Date (YTD) performance of 254.63%. Over the past year, the stock has seen a 288.89% change. These figures summarize PRAX's price movements across various periods, reflecting its historical returns.
According to current financial data, PRAX stock's P/E (TTM) ratio is -23.35, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for PRAX, including P/S (743.07), P/B (14.50), and P/FCF (-30.15), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.